Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine versus furosemide drip in children with oliguria
IRCT20130518013366N12Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dopamine and furosemide in oliguria (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Oliguria. Started Nov 2019; status: completed.
02
Drugs
dopaminefurosemide
03
Conditions
oliguria
Beyond the preview
Go deeper on IRCT20130518013366N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130518013366N12.